Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Yun T-K . Lancet Oncol 2001; 2:49–55.
Hasegawa H . J Pharmacol Sci 2004; 95:153–157.
Zhou W, Yan Q, Li JY, et al. J Appl Microbiol 2008; 104:699–706.
Sivakumar G, Yu K, Paek K . Eng Life Sci 2005; 5:527–533.
Dürr C, Hoffmeister D, Wohlert SE, et al. Angew Chem Int Ed Engl 2004; 43:2962–2965.
Paddon C, Westfall P, Pitera D, et al. Nature 2013; 496:528–532.
Han JY, Kim HJ, Kwon YS, et al. Plant Cell Physiol 2011; 52:2062–2073.
Tansakul P, Shibuya M, Kushiro T, et al. FEBS Lett 2006; 580:5143–5149.
Dai Z, Liu Y, Zhang X, et al. Metabolic Eng 2013; 20:146–156
Li C, Zhu Y, Guo X, et al. BMC Genomics 2013; 14:245.
Acknowledgements
This work was financially supported by National Basic Research Program of China (973 program, 2012CB721103), and the Knowledge Innovation Program from the Chinese Academy of Sciences (KSCX2-EW-G-13-1, KSCX2-EW-J-12). The hormone-autotrophic (H; habituated) Panax ginseng callus line, the plasmid pLLeu-tHMGR-UPC2.1, the C-terminal 6× His-tagged xylanase and the Arabidopsis thaliana cDNA were kindly provided by Prof Weiming Cai, Xueli Zhang, Dr Ning Liu and Wenjuan Cai, respectively. The authors thank Prof Peng Zhang, Yi Zhang, Yong Wang and Chen Yang for their advice. The authors also thank Prof Joan W Bennett (Rutgers University) and Dr David Stanley (USDA) for their critical reading of this manuscript and helpful suggestions.
Author information
Authors and Affiliations
Corresponding authors
Additional information
( Supplementary information is linked to the online version of the paper on the Cell Research website.)
Supplementary information
Supplementary information, Table S1
Bioactivities of compound K vs. those of PPD-type ginsenosides. (PDF 59 kb)
Supplementary information, Table S2
Datasets for construction of Genus Panax cDNA database (PDF 56 kb)
Supplementary information, Table S3
Characterized terpene glycosyltransferases collected in CAZy and UniprotKB databases (PDF 55 kb)
Supplementary information, Table S4
Production of CK and its precursor products in four genetically engineered strains. (PDF 142 kb)
Supplementary information, Table S5
The kinetic parameters of UGTPg1 towards PPD and DM as substrates (PDF 144 kb)
Supplementary information, Figure S1
The potential approaches for compound K manufacture. (PDF 99 kb)
Supplementary information, Figure S2
Unrooted tree dendrogram comparison of the amino acid sequences of glycosyltransferases. (PDF 183 kb)
Supplementary information, Figure S3
The construction of plasmids (A) and the recombinant yeast strains to yield CK (B) in this study. (PDF 378 kb)
Supplementary information, Figure S4
NMR spectra of CK produced by the engineered yeast strain AKl and by UGTPg1 in vitro reaction. (PDF 520 kb)
Supplementary information, Figure S5
SDS-PAGE (left) and anti-6×His Western blot (right) of the cell extract of the recombinant E. coli harboring pET28a and pET28a-UGTPg1. (PDF 133 kb)
Supplementary information, Figure S6
TLC analysis of reaction products catalyzed by UGTPg1 towards different substrates. (PDF 62 kb)
Supplementary information, Figure S7
NMR spectra of DMG produced by UGTPg1 in vitro reaction. (PDF 516 kb)
Supplementary information, Figure S8
Identification of DMG produced in the genetically engineered yeast strains. (PDF 385 kb)
Supplementary information, Figure S9
The in vitro reaction using the mixed substrate of PPD, Rh2 and Rg3 catalyzed by UGTPg1. (PDF 239 kb)
Supplementary information, Figure S10
The expression profiling of UGTPg1 and CYP716A47 in different tissues of P ginseng. (PDF 205 kb)
Supplementary information, Figure S11
Production of PPD from the strains BDI, BD2 and BD3 using ATR2-1 from Arabidopsis thaliana, PgCPR1 and PgCPR2 from Panax ginseng as the NADPH-cytochnxne P450 reductase, respectively. (PDF 87 kb)
Supplementary information, Data S1
Materials and methods (PDF 132 kb)
Rights and permissions
About this article
Cite this article
Yan, X., Fan, Y., Wei, W. et al. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res 24, 770–773 (2014). https://doi.org/10.1038/cr.2014.28
Published:
Issue date:
DOI: https://doi.org/10.1038/cr.2014.28
This article is cited by
-
Production of ginsenoside compound K by microbial cell factory using synthetic biology-based strategy: a review
Biotechnology Letters (2023)
-
Identification of two key UDP-glycosyltransferases responsible for the ocotillol-type ginsenoside majonside-R2 biosynthesis in Panax vietnamensis var. fuscidiscus
Planta (2023)
-
Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae
Communications Biology (2022)
-
Optimized biosynthesis of santalenes and santalols in Saccharomyces cerevisiae
Applied Microbiology and Biotechnology (2021)
-
Identification of two UDP-glycosyltransferases involved in the main oleanane-type ginsenosides in Panax japonicus var. major
Planta (2021)